University of Leicester
Mendelian randomization of blood lipids for coronary heart disease..pdf (676.49 kB)

Mendelian randomization of blood lipids for coronary heart disease

Download (676.49 kB)
journal contribution
posted on 2016-02-18, 10:30 authored by M. V. Holmes, F. W. Asselbergs, T. M. Palmer, F. Drenos, M. B. Lanktree, Christopher Paul Nelson, C. E. Dale, S. Padmanabhan, C. Finan, D. I. Swerdlow, V. Tragante, E. P. van Iperen, S. Sivapalaratnam, S. Shah, C. C. Elbers, T. Shah, J. Engmann, C. Giambartolomei, J. White, D. Zabaneh, R. Sofat, S. McLachlan, UCLEB consortium, P. A. Doevendans, A. J. Balmforth, A. S. Hall, K. E. North, B. Almoguera, R. C. Hoogeveen, M. Cushman, M. Fornage, S. R. Patel, S. Redline, D. S. Siscovick, M. Y. Tsai, K. J. Karczewski, M. H. Hofker, W. M. Verschuren, M. L. Bots, Y. T. van der Schouw, O. Melander, A. F. Dominiczak, R. Morris, Y. Ben-Shlomo, J. Price, M. Kumari, J. Baumert, A. Peters, B. Thorand, W. Koenig, T. R. Gaunt, S. E. Humphries, R. Clarke, H. Watkins, M. Farrall, J. G. Wilson, S. S. Rich, P. I. de Bakker, L. A. Lange, G. Davey Smith, A. P. Reiner, P. J. Talmud, M. Kivimäki, D. A. Lawlor, F. Dudbridge, N. J. Samani, B. J. Keating, A. D. Hingorani, J. P. Casas
AIMS: To investigate the causal role of high-density lipoprotein cholesterol (HDL-C) and triglycerides in coronary heart disease (CHD) using multiple instrumental variables for Mendelian randomization. METHODS AND RESULTS: We developed weighted allele scores based on single nucleotide polymorphisms (SNPs) with established associations with HDL-C, triglycerides, and low-density lipoprotein cholesterol (LDL-C). For each trait, we constructed two scores. The first was unrestricted, including all independent SNPs associated with the lipid trait identified from a prior meta-analysis (threshold P < 2 × 10(-6)); and the second a restricted score, filtered to remove any SNPs also associated with either of the other two lipid traits at P ≤ 0.01. Mendelian randomization meta-analyses were conducted in 17 studies including 62,199 participants and 12,099 CHD events. Both the unrestricted and restricted allele scores for LDL-C (42 and 19 SNPs, respectively) associated with CHD. For HDL-C, the unrestricted allele score (48 SNPs) was associated with CHD (OR: 0.53; 95% CI: 0.40, 0.70), per 1 mmol/L higher HDL-C, but neither the restricted allele score (19 SNPs; OR: 0.91; 95% CI: 0.42, 1.98) nor the unrestricted HDL-C allele score adjusted for triglycerides, LDL-C, or statin use (OR: 0.81; 95% CI: 0.44, 1.46) showed a robust association. For triglycerides, the unrestricted allele score (67 SNPs) and the restricted allele score (27 SNPs) were both associated with CHD (OR: 1.62; 95% CI: 1.24, 2.11 and 1.61; 95% CI: 1.00, 2.59, respectively) per 1-log unit increment. However, the unrestricted triglyceride score adjusted for HDL-C, LDL-C, and statin use gave an OR for CHD of 1.01 (95% CI: 0.59, 1.75). CONCLUSION: The genetic findings support a causal effect of triglycerides on CHD risk, but a causal role for HDL-C, though possible, remains less certain.



European Heart Journal, 2015, 36 (9), pp. 539-550

Author affiliation

/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Cardiovascular Sciences


  • VoR (Version of Record)

Published in

European Heart Journal





Acceptance date


Copyright date


Available date


Publisher version